Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre Study Comparing the Efficacy of Rosuvastatin With Atorvastatin When Given for a Period of 16 Wks to Subjects With Coronary Heart Disease & a Previously Performed Percutaneous Coronary Intervention

NCT00235950 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00235950
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00235950 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre Study Comparing the Efficacy of Rosuvastatin With Atorvastatin When Given for a Period of 16 Wks to Subjects With Coronary Heart Disease & a Previously Performed Percutaneous Coronary Intervention
Lead sponsor
AstraZeneca
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2004
Completion date
March 31, 2006
Enrollment
255
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

coronary heart disease